Dokümanı Olmayanlar: Recent submissions
Now showing items 521-540 of 184758
-
Investigation of Bioactivity Degradation During Storage of Sour Cherry (Prunus cerasus L.) Peel Extract
(2023)Introduction: Limited number of researches in the literature have been reported to examine degradation stability by regression methods. Monitoring storage stability of plant extracts containing phytochemicals has become a ... -
Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
(2023)Plasma cell dyscrasias (PCD) are a heterogeneous group of hematological diseases. The TMED9, KDELR1, DNAJC1, COPE, and LMAN2 genes identified from our transcriptome data are highly importance and specific. We determined ... -
Current pharmacological solutions for Behcet's syndrome
(2023)IntroductionBehcet's syndrome (BS) has a heterogeneous clinical phenotype, and its clinical manifestations may respond differently to drugs commonly used to treat BS. The type, dose, and duration of immunomodulatory, ... -
Why electrophysiological reassessment is needed? The experience of our laboratory - A cross-sectional study
(2022)Introduction: Requesting repetition of an electrodiagnostic examination (EDX) for follow-up and/or diagnostic verification is common in the daily practice of a reference center. Objective: This study aimed to evaluate ... -
Untitled
-
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group
(2022)Crizotinib is a multikinase inhibitor, effective in non-small cell lung cancer (NSCLC) harboring mesenchymal-epidermal transition (MET) alterations. Although small prospective studies showed efficacy and safety of crizotinib ...